{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-083830","form_type":"8-K","ticker":"ASMB","cik":"0001426800","company_name":"ASSEMBLY BIOSCIENCES, INC.","filed_at":"2025-06-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.262010+00:00","generated_at":"2026-05-19T16:58:26.271667+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Assembly Biosciences appoints new CFO; shareholders approve stock plan share increases","bullets":["Jeanette M. Bjorkquist appointed principal financial officer effective June 5, 2025; Jason A. Okazaki remains CEO.","Shareholders approved Amendment No. 1 to 2018 Stock Incentive Plan: shares reserved increased by 375,000 to 1,478,333.","Amendment No. 2 approved: 225,000 additional shares for performance-based vesting retention grants.","ESPP Amendment No. 1 approved: shares reserved increased from 164,500 to 225,000.","All 10 director nominees elected; Ernst & Young ratified as auditor for FY 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-083830","json":"https://secwatch.observer/filing/0000950170-25-083830.json","markdown":"https://secwatch.observer/filing/0000950170-25-083830.md","text":"https://secwatch.observer/filing/0000950170-25-083830.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025083830/0000950170-25-083830-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025083830/asmb-20250605.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T16:58:26.271667+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"59b7f873d6","claim":"Jeanette M. Bjorkquist was appointed as principal financial officer at ASSEMBLY BIOSCIENCES, INC..","evidence_excerpt":"On June 5, 2025, the Board of Directors appointed Jeanette M. Bjorkquist to serve as the Company’s principal financial officer in addition to her role as principal accounting officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025083830/0000950170-25-083830-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"principal financial officer"}],"fact_type":"executive_change"},{"claim_id":"c5ff9a4131","claim":"Jason A. Okazaki changed role as principal executive officer at ASSEMBLY BIOSCIENCES, INC..","evidence_excerpt":"Ms. Bjorkquist succeeds Jason A. Okazaki, who previously served as both the Company’s principal executive officer and principal financial officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1426800/000095017025083830/0000950170-25-083830-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Role","value":"principal executive officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}